These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9339481)

  • 21. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity.
    Naciff JM; Daston GP
    Toxicol Pathol; 2004; 32 Suppl 2():59-70. PubMed ID: 15503665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407).
    Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Folkerts A; Stahl B; Kayser M
    Arch Toxicol; 2002 May; 76(4):194-202. PubMed ID: 12029382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine disruptors: overview and a pathologist's perspective.
    Kennedy S
    Toxicol Pathol; 2000; 28(3):418-9. PubMed ID: 10862559
    [No Abstract]   [Full Text] [Related]  

  • 25. Vulnerability of the endocrine system to xenobiotic influence.
    Neubert D
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):9-29. PubMed ID: 9339474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program.
    Borgert CJ; Mihaich EM; Ortego LS; Bentley KS; Holmes CM; Levine SL; Becker RA
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):185-91. PubMed ID: 21803110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide.
    Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Becka M
    Arch Toxicol; 2001 Apr; 75(2):65-73. PubMed ID: 11354908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
    Freyberger A; Scholz G
    ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
    Ankley GT; Gray LE
    Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition, classification and mechanism of action of endocrine disrupting chemicals.
    Wuttke W; Jarry H; Seidlova-Wuttke D
    Hormones (Athens); 2010; 9(1):9-15. PubMed ID: 20363717
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of EPA's endocrine screening battery and recommendations for further review.
    Schapaugh AW; McFadden LG; Zorrilla LM; Geter DR; Stuchal LD; Sunger N; Borgert CJ
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):552-61. PubMed ID: 26044367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine active agents: implications of adverse and non-adverse changes.
    Foster PM; McIntyre BS
    Toxicol Pathol; 2002; 30(1):59-65. PubMed ID: 11892727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A testing strategy for the identification of mammalian, systemic endocrine disruptors with particular focus on steroids.
    Kolle SN; Ramirez T; Kamp HG; Buesen R; Flick B; Strauss V; van Ravenzwaay B
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):259-78. PubMed ID: 22554500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats.
    Marty MS; Crissman JW; Carney EW
    Toxicol Sci; 2001 Apr; 60(2):285-95. PubMed ID: 11248141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological regulation of receptor-hormone complex concentrations in relation to dose-response assessments for endocrine-active compounds.
    Andersen ME; Barton HA
    Toxicol Sci; 1999 Mar; 48(1):38-50. PubMed ID: 10330682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of (anti-) androgenic or estrogenic effects of three pyrethroids (esfenvalerate, fenvalerate, and permethrin) in the Hershberger and uterotrophic assays.
    Kunimatsu T; Yamada T; Ose K; Sunami O; Kamita Y; Okuno Y; Seki T; Nakatsuka I
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):227-37. PubMed ID: 12052007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats.
    Laws SC; Carey SA; Ferrell JM; Bodman GJ; Cooper RL
    Toxicol Sci; 2000 Mar; 54(1):154-67. PubMed ID: 10746942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide.
    Kim HS; Shin JH; Moon HJ; Kim TS; Kang IH; Seok JH; Kim IY; Park KL; Han SY
    Toxicol Sci; 2002 May; 67(1):52-62. PubMed ID: 11961216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response relationships for endocrine disruptors: what we know and what we don't know.
    Lucier GW
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):34-5. PubMed ID: 9339476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.